• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Twelve-month outcomes of the TaurusOne ® Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis
CONCLUSIONS: The 1-year clinical results confirm the safety and efficacy of the TaurusOne® transcatheter aortic valve system in the treatment of patients with symptomatic severe tricuspid and bicuspid aortic stenosis.PMID:34338639 | DOI:10.4244/EIJ-D-21-00040
Source: EuroIntervention - August 2, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Moyang Wang Guangyuan Song Mao Chen Yuan Feng Jian'an Wang Xianbao Liu Shenghua Zhou Zhenfei Fang Yaling Han Kai Xu Bo Yu Bo Xu Yuejin Yang Nicolo Piazza Yongjian Wu Runlin Gao Source Type: research

A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system.
CONCLUSIONS: Our study provides further evidence on the safety and efficacy of the J-Valve in high-risk patients with AS or AR for surgery. PMID: 30064947 [PubMed - as supplied by publisher]
Source: Journal of Cardiology - July 28, 2018 Category: Cardiology Authors: Tung M, Wang X, Li F, Wang H, Guo Y, Wang C, Wei L, Luo X, Wang X, Wang W Tags: J Cardiol Source Type: research

Transcatheter aortic valve implantation: initial experience in Hong Kong.
CONCLUSIONS: Transcatheter aortic valve implantation has been developed as an alternative treatment for patients with symptomatic severe aortic stenosis who are deemed inoperable or high risk for surgery. Our results are very promising and comparable with those of major clinical trials. PMID: 28655865 [PubMed - as supplied by publisher]
Source: Hong Kong Med J - June 28, 2017 Category: General Medicine Authors: Lee MK, Chui SF, Chan AK, Chan JL, Wong EC, Chan KT, Cheung HL, Chiang CS Tags: Hong Kong Med J Source Type: research